Follow on Google News News By Tag Industry News * Pharmaceuticals * More Industries... News By Location Country(s) Industry News
Follow on Google News | SMi's Controlled Release conference held on 28th & 29th March 2012, LondonHow to select the most apporpriate formulation tool for poorly soluble drugs
By: SMi Group Don’t miss out on this fantastic opportunity to network with experts in the field such as: • Peter Timmins, Executive Director, Drug Products, Science and Technology, Bristol-Myers Squibb • Simon Holland, Director, Process Understanding & Control, GlaxoSmithKline • Bernd Riebesehl, Principal Fellow, Parenteral Dosage Forms, Pharmaceutical and Analytical Development, Novartis • Mostafa Nakach, Head of the Pharmaceutical Engineering Group, Sanofi-Aventis • Michael Keller, Senior Fellow, siRNA Project Leader, Technical Research and Development (TRD), Novartis • Tomas Landh, Director, Novo Nordisk • Jan L. Powell, Director, Physiology, Shire HGT • Lars Bauer, Senior Medical Director, Therapeutic Area CNS, UCB • Karin Liltorp, Director, Preformulation, Lundbeck • Mario Maio, Director of Formulation & Process Development, Merck Serono • Bernardo Perez-Ramírez, Senior Scientific Director, BioFormulations Development, Genzyme • Marcio Temtem, Process Development Engineer, Hovione There will also be two interactive pre-conference workshops held on the 27th March 2012 on..... A. Accelerating first-in-human studies (FIH) with lipid-based formulations Hosted by: David J. Hauss, Principal, Hauss Associates Hassan Benameur, Senior Director Pharmaceutical Sciences, Capsugel Senior Representative, Gattefossé 8.30am-12.30pm B. A trip through the life and work of a patent Hosted by: Jonathan Couchman, Partner, Harrison Goddard Foote (HGF) & Martyn Fish, Partner, HGF Law 1.30pm-5.30pm For more information and to book your place visit http://www.smi- Alternatively, contact Andrew Gibbons at Tel: +44 (0)20 7827 6156 or Email: agibbons@smi- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|